Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.

@article{Matsuo2011PrognosticFI,
  title={Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.},
  author={Yukinori Matsuo and Keiko Shibuya and Yasushi Nagata and Kenji Takayama and Yoshiki Norihisa and Takashi Mizowaki and Masaru Narabayashi and Katsuyuki Sakanaka and Masahiro Hiraoka},
  journal={International journal of radiation oncology, biology, physics},
  year={2011},
  volume={79 4},
  pages={1104-11}
}
PURPOSE To investigate the factors that influence clinical outcomes after stereotactic body radiotherapy (SBRT) for non-small-cell lung cancer (NSCLC). METHODS AND MATERIALS A total of 101 consecutive patients who underwent SBRT with 48 Gy in 4 fractions for histologically confirmed Stage I NSCLC were enrolled in this study. Factors including age, maximal tumor diameter, sex, performance status, operability, histology, and overall treatment time were evaluated with regard to local progression… CONTINUE READING

8 Figures & Tables

Connections & Topics

Mentioned Connections BETA
To investigate the factors that influence clinical outcomes after stereotactic body radiotherapy ( SBRT ) for non - small - cell lung cancer ( NSCLC ) .
To investigate the factors that influence clinical outcomes after stereotactic body radiotherapy ( SBRT ) for non - small - cell lung cancer ( NSCLC ) .
To investigate the factors that influence clinical outcomes after stereotactic body radiotherapy ( SBRT ) for non - small - cell lung cancer ( NSCLC ) .
All Topics